Firefly Neuroscience Inc (AIFF)

$2.79 +0.12 (4.49%)
Market Cap 34.34M
Revenue (ttm) 110,000.00
Net Income (ttm) -10.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,509.09%
Debt to Equity Ratio 0.00
Volume 174,700
Avg Vol 1,302,898
Day's Range N/A - N/A
Shares Out 12.86M
Stochastic %K 34%
Beta 3.20
Analysts Strong Buy
Price Target N/A

Company Profile

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serv...

Industry: Software - Application
Sector: Technology
Phone: 888-237-6412
Address:
1100 Military Road, Kenmore, United States
BioTuesdays
BioTuesdays Aug. 4 at 7:40 PM
Cognito Therapeutics, Inc. presents positive Spectris data at AAIC; highlights Firefly Neuroscience collaboration for biomarker discovery using BNA technology $AIFF https://biotuesdays.com/2025/08/04/cognito-presents-positive-spectris-data-at-aaic-highlights-firefly-collaboration-for-biomarker-discovery-using-bna-technology/
0 · Reply
Kumajoey
Kumajoey Jul. 30 at 3:06 PM
$AIFF Over 15 yrs, they've poured ~$60M into BNA platform dev, building a massive EEG database & patents—now supercharged by Evoke acquisition (180k+ records, 27 new patents)! Recent Heidelberg collab w/ Prof. Schaaf (3 syndromes named after him) on 15q13.3 CNV biomarkers could revolutionize rare neuro disorder diagnostics thru 2026. Plus, June research hit 87% accuracy differentiating Alzheimer's stages. Long-term upside huge, but watch the burn—early play!
1 · Reply
Kumajoey
Kumajoey Jul. 30 at 2:51 PM
$AIFF looking like a hidden gem in AI healthcare! 🚀 FDA-cleared BNA platform, NVIDIA Connect access, Heidelberg deal & Evoke acquisition could spark 100-300% rev growth from tiny base. No debt, solid cash runway—huge upside if licensing ramps. Early stage w/ burn risks, but bullish on AI diagnostics
1 · Reply
SmartRetail90
SmartRetail90 Jul. 27 at 12:13 PM
$AIFF come to ANAB JP Morgan just gave it a $80 PT, stock is trading at 26 with 56% short interest! These are the setups that trigger a violent short squeeze. Don't miss out 👉🏻 ANAB
1 · Reply
Olg59
Olg59 Jul. 24 at 7:37 PM
$AIFF Adding under 3.00
0 · Reply
Dilutable
Dilutable Jul. 24 at 12:26 PM
$LIDR Think carefully before you sell for pennies or $1/share profit. $AIFF had much weaker $NVDA news a few months back and ended up hitting 15+ from about $3-4/share over the course of a few days.
0 · Reply
Dilutable
Dilutable Jul. 24 at 12:20 PM
$LIDR So who remembers what $AIFF did after (less significant) $NVDA news a number of months back? Very similar low-float setup. Is 4-6X in a sustained runup over the next few days in the cards here also?
0 · Reply
justlurkingforstocks
justlurkingforstocks Jul. 23 at 6:13 PM
$AIFF
0 · Reply
elgreg
elgreg Jul. 23 at 6:02 PM
$AIFF Day flippers and short sellers, for now!
0 · Reply
Olg59
Olg59 Jul. 17 at 1:55 PM
$AIFF Added yesterday under 2.77...Nearest PT 5
0 · Reply
Latest News on AIFF
Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Jul 14, 2025, 7:45 AM EDT - 21 days ago

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Neuroscience to be Added to the Russell Microcap® Index

Jun 23, 2025, 8:05 AM EDT - 6 weeks ago

Firefly Neuroscience to be Added to the Russell Microcap® Index

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Jun 20, 2025, 7:45 AM EDT - 6 weeks ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 9:00 PM EDT - 3 months ago

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 7:45 AM EDT - 3 months ago

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Mar 6, 2025, 7:30 AM EST - 5 months ago

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 21, 2025, 8:00 AM EST - 5 months ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 11, 2025, 7:45 AM EST - 6 months ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Feb 7, 2025, 7:30 AM EST - 6 months ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Jan 14, 2025, 12:25 PM EST - 7 months ago

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Jan 14, 2025, 7:45 AM EST - 7 months ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Dec 31, 2024, 9:00 AM EST - 7 months ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 14, 2024, 5:30 PM EST - 9 months ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Nov 6, 2024, 9:00 AM EST - 9 months ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 25, 2024, 4:10 PM EDT - 10 months ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 16, 2024, 9:20 AM EDT - 10 months ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 10 months ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Sep 10, 2024, 9:00 AM EDT - 11 months ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 26, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 21, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

Aug 13, 2024, 4:06 PM EDT - 1 year ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

BioTuesdays
BioTuesdays Aug. 4 at 7:40 PM
Cognito Therapeutics, Inc. presents positive Spectris data at AAIC; highlights Firefly Neuroscience collaboration for biomarker discovery using BNA technology $AIFF https://biotuesdays.com/2025/08/04/cognito-presents-positive-spectris-data-at-aaic-highlights-firefly-collaboration-for-biomarker-discovery-using-bna-technology/
0 · Reply
Kumajoey
Kumajoey Jul. 30 at 3:06 PM
$AIFF Over 15 yrs, they've poured ~$60M into BNA platform dev, building a massive EEG database & patents—now supercharged by Evoke acquisition (180k+ records, 27 new patents)! Recent Heidelberg collab w/ Prof. Schaaf (3 syndromes named after him) on 15q13.3 CNV biomarkers could revolutionize rare neuro disorder diagnostics thru 2026. Plus, June research hit 87% accuracy differentiating Alzheimer's stages. Long-term upside huge, but watch the burn—early play!
1 · Reply
Kumajoey
Kumajoey Jul. 30 at 2:51 PM
$AIFF looking like a hidden gem in AI healthcare! 🚀 FDA-cleared BNA platform, NVIDIA Connect access, Heidelberg deal & Evoke acquisition could spark 100-300% rev growth from tiny base. No debt, solid cash runway—huge upside if licensing ramps. Early stage w/ burn risks, but bullish on AI diagnostics
1 · Reply
SmartRetail90
SmartRetail90 Jul. 27 at 12:13 PM
$AIFF come to ANAB JP Morgan just gave it a $80 PT, stock is trading at 26 with 56% short interest! These are the setups that trigger a violent short squeeze. Don't miss out 👉🏻 ANAB
1 · Reply
Olg59
Olg59 Jul. 24 at 7:37 PM
$AIFF Adding under 3.00
0 · Reply
Dilutable
Dilutable Jul. 24 at 12:26 PM
$LIDR Think carefully before you sell for pennies or $1/share profit. $AIFF had much weaker $NVDA news a few months back and ended up hitting 15+ from about $3-4/share over the course of a few days.
0 · Reply
Dilutable
Dilutable Jul. 24 at 12:20 PM
$LIDR So who remembers what $AIFF did after (less significant) $NVDA news a number of months back? Very similar low-float setup. Is 4-6X in a sustained runup over the next few days in the cards here also?
0 · Reply
justlurkingforstocks
justlurkingforstocks Jul. 23 at 6:13 PM
$AIFF
0 · Reply
elgreg
elgreg Jul. 23 at 6:02 PM
$AIFF Day flippers and short sellers, for now!
0 · Reply
Olg59
Olg59 Jul. 17 at 1:55 PM
$AIFF Added yesterday under 2.77...Nearest PT 5
0 · Reply
elgreg
elgreg Jul. 16 at 8:29 PM
$AIFF This is why the potential to identify changes in cognitive acuity highlighting specific markers strongly indicating possible Alzheimer’s/dementia/ADHD/ Traumatic head! TAM (Total Addressable Market) Expansion Alzheimer’s costs the US over $300B annually, with ~6 million Americans currently living with the disease. The early detection and monitoring market for Alzheimer’s is projected to grow to $2B–$5B globally within this decade. Firefly’s BNA could capture a significant share if it: Shows high sensitivity/specificity. Gains reimbursement coverage. Becomes integrated into clinical workflows as a frontline or adjunctive tool.
0 · Reply
Oooox
Oooox Jul. 16 at 4:57 PM
$AIFF
0 · Reply
Oooox
Oooox Jul. 16 at 4:23 PM
$AIFF 🔥🔥🔥🔥🔥
0 · Reply
Niconiconee
Niconiconee Jul. 16 at 3:28 PM
$AIFF 👀
0 · Reply
apextraders007
apextraders007 Jul. 16 at 2:12 PM
$DARE $SDST $SONN $AIFF $BTCM
0 · Reply
elgreg
elgreg Jul. 15 at 10:13 PM
$AIFF TAM (Total Addressable Market) Expansion Alzheimer’s costs the US over $300B annually, with ~6 million Americans currently living with the disease. The early detection and monitoring market for Alzheimer’s is projected to grow to $2B–$5B globally within this decade. Firefly’s BNA could capture a significant share if it: Shows high sensitivity/specificity. Gains reimbursement coverage. Becomes integrated into clinical workflows as a frontline or adjunctive tool.
0 · Reply
elgreg
elgreg Jul. 15 at 10:12 PM
$AIFF TAM (Total Addressable Market) Expansion Alzheimer’s costs the US over $300B annually, with ~6 million Americans currently living with the disease. The early detection and monitoring market for Alzheimer’s is projected to grow to $2B–$5B globally within this decade. Firefly’s BNA could capture a significant share if it: Shows high sensitivity/specificity. Gains reimbursement coverage. Becomes integrated into clinical workflows as a frontline or adjunctive tool.
0 · Reply
elgreg
elgreg Jul. 15 at 3:18 PM
$AIFF Massive Manipulation!
2 · Reply
only1mc
only1mc Jul. 14 at 10:20 PM
$WINT gained 49% this morning. took a couple more shots st it but cut quickly. little disappointed but still walked away a winner $AIFF small loss disappointed shorts won $CLIK also disappointed broke just over even no money baskets today but riding$BLMZ into tomorrow land. tomorrow will be the day .
0 · Reply
Interstark
Interstark Jul. 14 at 10:20 PM
$AIFF buy more or just take the loss.
0 · Reply
KingDiego
KingDiego Jul. 14 at 10:15 PM
$AIFF Due for a bigger move imo
0 · Reply
ddickinv
ddickinv Jul. 14 at 3:10 PM
$AIFF If it is such a big deal, why won't AIFF hold its gains?
3 · Reply